- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05267847
The Success Rate of Cryotherapy Application in Primary Molars With Signs of Irreversible Pulpitis
March 2, 2022 updated by: Ahmad Elheeny, Minia University
The Success Rate of Cryotherapy Application in Primary Molars With Signs of Irreversible
The study is designed as a randomized controlled trial with two parallel groups.
Children aged 5-9 years with primary molars from suffered symptomatic signs of irreversible pulpitis will be randomly assigned into two groups.
The first group (experimental group) will be injected with 4% articaine 1:100.000
epinephrine (inferior alveolar nerve block).
For the second group, the mandibular second primary molars will be anesthetized using 4% articaine 1:100.000
epinephrine using inferior alveolar nerve block.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
188
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Al Minyā, Egypt, 61111
- Recruiting
- Omar Ahmed
-
Contact:
- Omar Ahmed, PhD
- Phone Number: 0020862347768
- Email: EG135.30708112400351@nies-edu.org
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 years to 9 years (CHILD)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy children are classified as I or II according to ASA
- Presence of at least one mandibular primary molar with symptomatic signs of irreversible pulpitis
- Presence of at least two-thirds of the root length in periapical radiograph
Exclusion Criteria:
- Unrestorable crowns
- Children with systemic, severe behavior or emotional problems
- Presence of gingival redness, swellings, fistulous of sinus tract
- Radiographic evidence of internal root resorption, pulp stones or calcifications, and/or bone radiolucency
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Cryotherapy during inferior alveolar nerve block
|
local anesthetic injection with articaine 4% 1:100,000 epinephrine then an application ice packs
|
ACTIVE_COMPARATOR: Inferior alveolar nerve block
|
local anesthetic injection with articaine 4% 1:100,000 epinephrine
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain assessment
Time Frame: up to 24 hours
|
Wong Backer pain scale
|
up to 24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
February 22, 2022
Primary Completion (ANTICIPATED)
April 30, 2022
Study Completion (ANTICIPATED)
April 30, 2022
Study Registration Dates
First Submitted
February 22, 2022
First Submitted That Met QC Criteria
March 2, 2022
First Posted (ACTUAL)
March 4, 2022
Study Record Updates
Last Update Posted (ACTUAL)
March 4, 2022
Last Update Submitted That Met QC Criteria
March 2, 2022
Last Verified
March 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 133
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain, Procedural
-
IRCCS Burlo GarofoloCompletedProcedural Pain ReliefItaly
-
Defense and Veterans Center for Integrative Pain...DepomedCompletedMinor Procedural PainUnited States
-
IWK Health CentreCompletedNeonatal Procedural Pain ResponseCanada
-
Beth Israel Deaconess Medical CenterRecruitingProcedural Pain | Pain Catastrophizing | Procedural AnxietyUnited States
-
University of UtahCompleted
-
University Hospital, BrestCompletedPrevention of the Procedural Pain in the NewbornFrance
-
Hamad Medical CorporationRecruitingProcedural Pain | Procedural AnxietyQatar
-
Nationwide Children's HospitalEnrolling by invitationProcedural Pain | Procedural AnxietyUnited States
-
Central Hospital, Nancy, FranceUnknownVirtual Reality | Procedural Pain | Procedural AnxietyFrance
-
University of YalovaRecruiting
Clinical Trials on Cryotherapy
-
Cairo UniversityNot yet recruiting
-
Creighton UniversityCompleted
-
Azienda Ospedaliera San Camillo ForlaniniCompleted
-
Hanyang University Seoul HospitalCompletedCryotherapy EffectKorea, Republic of
-
Ondokuz Mayıs UniversityRecruitingPain, Postoperative | Pulpitis | Caries; DentinTurkey
-
Entellus Medical, Inc.North American Science Associates Inc.Active, not recruiting
-
CSA Medical, Inc.WithdrawnLung Diseases, Obstructive | Airway Obstruction | Lung Disease Airways | Airway; Obstruction, With Emphysema
-
Unity Health TorontoRecruitingRetinal Detachment | MetamorphopsiaCanada
-
Flávia CarvalhoNot yet recruitingFunctional Status | Muscle Tone
-
Sohag UniversityMansoura UniversityNot yet recruitingObstructive Sleep Apnea Syndrome